Lawmakers are getting angry over a new price hike for a drug, this time targeting a cancer drug whose price was raised four times this year alone.
Former presidential candidate Sen. Bernie Sanders, I-Vt., and Rep. Elijah Cummings, D-Md., sent a letter Thursday to Ariad Pharmaceuticals for answers about Iclusig, which treats a bone marrow cancer that makes too many white blood cells. Sanders and Cummings, who have targeted high-priced drugs, said Ariad has added more than $80,000 to the drug’s already high price tag this year.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
